Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

SNSS

Sunesis Pharmaceuticals (SNSS)

Sunesis Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SNSS
DateTimeSourceHeadlineSymbolCompany
03/22/20177:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Announces Submission of Responses to the EMA Day 180 List of Outstanding Issues for Marketing Authori...NASDAQ:SNSSSunesis Pharmaceuticals Inc
03/09/20174:35PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
03/09/20179:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
03/09/20177:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2016 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
03/02/20177:00AMGlobeNewswire Inc.Sunesis to Host Conference Call on March 9th to Discuss Fourth Quarter and Full-Year 2016 Financial Results and Recent Highli...NASDAQ:SNSSSunesis Pharmaceuticals Inc
03/01/20177:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals to Present at the Cowen and Company 37th Annual Health Care ConferenceNASDAQ:SNSSSunesis Pharmaceuticals Inc
02/15/20177:09AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/14/20175:59PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/14/20174:27PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/14/20174:21PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/14/20171:26PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/14/201712:43PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/06/20177:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals to Present at the 19th Annual BIO CEO & Investor ConferenceNASDAQ:SNSSSunesis Pharmaceuticals Inc
01/23/20177:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Announces Clinical and Regulatory Updates to SNS-062 and Vosaroxin ProgramsNASDAQ:SNSSSunesis Pharmaceuticals Inc
01/13/20176:03AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/06/20174:52PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/16/20165:55PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/12/20166:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/05/20165:45PMGlobeNewswire Inc.Sunesis Pharmaceuticals Announces Presentation of Updated Results from the VALOR Trial Examining Overall Survival in Patients...NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/05/20167:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Announces Presentation of Results from Completed Phase 1A Healthy Volunteer Study Evaluating Oral Non...NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/03/20163:31PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/03/20169:25AMGlobeNewswire Inc.Sunesis Pharmaceuticals Announces Presentations at ASH Annual MeetingNASDAQ:SNSSSunesis Pharmaceuticals Inc
11/03/20167:07AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/03/20167:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Reports Third Quarter 2016 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
10/31/20164:46PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SNSSSunesis Pharmaceuticals Inc
10/27/20167:00AMGlobeNewswire Inc.Sunesis to Host Conference Call on November 3rd to Discuss Third Quarter 2016 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
10/24/20164:05PMGlobeNewswire Inc.Sunesis Announces Closing of Public Offerings and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:SNSSSunesis Pharmaceuticals Inc
10/20/20166:04AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
10/20/20166:04AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
10/19/20164:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SNSS

Your Recent History

Delayed Upgrade Clock